Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP466044.RAkVA2GPijZNxlAuR3l_gIbn3bV2zP8Ze1bJth4Aslc-E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP466044.RAkVA2GPijZNxlAuR3l_gIbn3bV2zP8Ze1bJth4Aslc-E130_assertion type Assertion NP466044.RAkVA2GPijZNxlAuR3l_gIbn3bV2zP8Ze1bJth4Aslc-E130_head.
- NP466044.RAkVA2GPijZNxlAuR3l_gIbn3bV2zP8Ze1bJth4Aslc-E130_assertion description "[Importantly, we observed that the combination of PI3K-mTOR and MEK inhibitors effectively shrunk tumors in a transgenic and xenograft model of EGFR T790M-L858R cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP466044.RAkVA2GPijZNxlAuR3l_gIbn3bV2zP8Ze1bJth4Aslc-E130_provenance.
- NP466044.RAkVA2GPijZNxlAuR3l_gIbn3bV2zP8Ze1bJth4Aslc-E130_assertion evidence source_evidence_literature NP466044.RAkVA2GPijZNxlAuR3l_gIbn3bV2zP8Ze1bJth4Aslc-E130_provenance.
- NP466044.RAkVA2GPijZNxlAuR3l_gIbn3bV2zP8Ze1bJth4Aslc-E130_assertion SIO_000772 19850869 NP466044.RAkVA2GPijZNxlAuR3l_gIbn3bV2zP8Ze1bJth4Aslc-E130_provenance.
- NP466044.RAkVA2GPijZNxlAuR3l_gIbn3bV2zP8Ze1bJth4Aslc-E130_assertion wasDerivedFrom befree-20140225 NP466044.RAkVA2GPijZNxlAuR3l_gIbn3bV2zP8Ze1bJth4Aslc-E130_provenance.
- NP466044.RAkVA2GPijZNxlAuR3l_gIbn3bV2zP8Ze1bJth4Aslc-E130_assertion wasGeneratedBy ECO_0000203 NP466044.RAkVA2GPijZNxlAuR3l_gIbn3bV2zP8Ze1bJth4Aslc-E130_provenance.